184 related articles for article (PubMed ID: 2839199)
1. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.
Fletcher KA; Barton PF; Kelly JA
Biochem Pharmacol; 1988 Jul; 37(13):2683-90. PubMed ID: 2839199
[TBL] [Abstract][Full Text] [Related]
2. Oxidative activity of hydroxylated primaquine analogs. Non-toxicity to glucose-6-phosphate dehydrogenase-deficient human red blood cells in vitro.
Baird JK; Davidson DE; Decker-Jackson JE
Biochem Pharmacol; 1986 Apr; 35(7):1091-8. PubMed ID: 3754445
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of certain hydroxy analogues of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes.
Allahyari R; Strother A; Fraser IM; Verbiscar AJ
J Med Chem; 1984 Mar; 27(3):407-10. PubMed ID: 6699888
[TBL] [Abstract][Full Text] [Related]
4. Primaquine-mediated oxidative metabolism in the human red cell. Lack of dependence on oxyhemoglobin, H2O2 formation, or glutathione turnover.
Kelman SN; Sullivan SG; Stern A
Biochem Pharmacol; 1982 Jul; 31(14):2409-14. PubMed ID: 7126253
[TBL] [Abstract][Full Text] [Related]
5. Studies with primaquine in vitro: superoxide radical formation and oxidation of haemoglobin.
Summerfield M; Tudhope GR
Br J Clin Pharmacol; 1978 Oct; 6(4):319-23. PubMed ID: 212091
[TBL] [Abstract][Full Text] [Related]
6. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
Ganesan S; Chaurasiya ND; Sahu R; Walker LA; Tekwani BL
Toxicology; 2012 Mar; 294(1):54-60. PubMed ID: 22330256
[TBL] [Abstract][Full Text] [Related]
7. Contributions of superoxide, hydrogen peroxide, and transition metal ions to auto-oxidation of the favism-inducing pyrimidine aglycone, divicine, and its reactions with haemoglobin.
Winterbourn CC; Benatti U; De Flora A
Biochem Pharmacol; 1986 Jun; 35(12):2009-15. PubMed ID: 3013207
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites--I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin.
Agarwal S; Gupta UR; Gupta RC; Anand N; Agarwal SS
Biochem Pharmacol; 1988 Dec; 37(24):4605-9. PubMed ID: 3202898
[TBL] [Abstract][Full Text] [Related]
9. Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro.
Baird JK; McCormick GJ; Canfield CJ
Biochem Pharmacol; 1986 Apr; 35(7):1099-106. PubMed ID: 3754446
[TBL] [Abstract][Full Text] [Related]
10. Change of deformability and Heinz body formation in G6PD-deficient erythrocytes treated with 5-hydroxy-6-desmethylprimaquine.
Thompson SF; Fraser IM; Strother A; Bull BS
Blood Cells; 1989; 15(2):443-52; discussion 453-4. PubMed ID: 2765673
[TBL] [Abstract][Full Text] [Related]
11. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
[TBL] [Abstract][Full Text] [Related]
12. Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo.
Vásquez-Vivar J; Augusto O
Biochem Pharmacol; 1994 Jan; 47(2):309-16. PubMed ID: 8304975
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
14. Protection by ascorbate against acetylphenylhydrazine-induced Heinz body formation in glucose-6-phosphate dehydrogenase deficient erythrocytes.
Winterbourn CC
Br J Haematol; 1979 Feb; 41(2):245-22. PubMed ID: 427033
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates.
Link CM; Theoharides AD; Anders JC; Chung H; Canfield CJ
Toxicol Appl Pharmacol; 1985 Nov; 81(2):192-202. PubMed ID: 4060148
[TBL] [Abstract][Full Text] [Related]
16. NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Scott MD; Zuo L; Lubin BH; Chiu DT
Blood; 1991 May; 77(9):2059-64. PubMed ID: 2018843
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation and haemoglobin degradation in red blood cells exposed to t-butyl hydroperoxide. The relative roles of haem- and glutathione-dependent decomposition of t-butyl hydroperoxide and membrane lipid hydroperoxides in lipid peroxidation and haemolysis.
Trotta RJ; Sullivan SG; Stern A
Biochem J; 1983 Jun; 212(3):759-72. PubMed ID: 6882393
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of erythrocyte superoxide dismutase by diethyldithiocarbamate also results in oxyhemoglobin-catalyzed glutathione depletion and methemoglobin production.
Kelner MJ; Alexander NM
J Biol Chem; 1986 Feb; 261(4):1636-41. PubMed ID: 3003078
[TBL] [Abstract][Full Text] [Related]
19. Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man.
Carson PE; Hohl R; Nora MV; Parkhurst GW; Ahmad T; Scanlan S; Frischer H
Bull World Health Organ; 1981; 59(3):427-37. PubMed ID: 6976850
[TBL] [Abstract][Full Text] [Related]
20. Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Fraser IM; Vesell ES
J Pharmacol Exp Ther; 1968 Jul; 162(1):155-65. PubMed ID: 5656594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
